semaglutide and anaesthesia GLP-1 receptor agonists like (Ozempic, Wegovy) tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These Weight-loss drugs may raise risk

Discuss with your healthcare provider the option of lowering the dose, slowing the titration schedule, or switching to a different treatment

I continue to come and get the Amazing results and wonderful staff

The medication's effectiveness stems from its dual action: it helps control blood sugar and slows down stomach emptying [6]

These alleles are linked to increased steatosis, MASH, and a higher risk of hepatocellular carcinoma [42]

However, they do not contain actual GLP-1 or its direct synthetic counterparts, which are the basis of prescription GLP-1 receptor agonist medications

Instead, they should explain that gallbladder events are uncommon but possible, especially during periods of rapid weight reduction